Merck Annual Report 2000 Merck Annual Report 2000 [Contents] 16 of 18
[Previous][Contents][Next]
[Products] [Financial Highlights] [Letter] [Innovation] [Access] [People] [Financials] [Management] [Corporate Info]
MANAGEMENT

Management Committee
Management Committee
Left to right, David W. Anstice, 52, president, Human Health – The Americas since 1997;
Adel Mahmoud, M.D., Ph.D., 59, president, Merck Vaccines since 1999;
Wendy L. Yarno, 46, senior vice president, Human Resources since 1999;
Richard T. Clark, 55, president, Merck-Medco Managed Care, L.L.C., since 2000;
Kenneth C. Frazier, 46, senior vice president and general counsel since 1999;
Raymond V. Gilmartin, 60, chairman, president and chief executive officer since 1994;
Judy C. Lewent, 52, executive vice president and chief financial officer since 1993;
Bernard J. Kelley, 59, president, Merck Manufacturing Division since 1993;
Edward M. Scolnick, M.D., 60, executive vice president, science and technology, and president, Merck Research Laboratories since 1993;
Paul R. Bell, 55, president, Human Health – Asia Pacific since 1997;
Per Wold-Olsen, 53, president, Human Health – Europe, Middle East and Africa since 1997. Click here for more. [More]


Back to top
[Contents] 16 of 18
[Previous][Contents][Next]
[Products] [Financial Highlights] [Letter] [Innovation] [Access] [People] [Financials] [Management] [Corporate Info]
Merck Annual Report 2000 Merck Annual Report 2000
Copyright © 1995-2001 Merck & Co., Inc., Whitehouse Station, NJ, USA. All rights reserved.

Board of DirectorsManagement Committee